Status:
COMPLETED
BTT-1023 in Rheumatoid Arthritis
Lead Sponsor:
Biotie Therapies Corp.
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
Patients with adult-onset rheumatoid arthritis will be enrolled. They will be dosed with repeated intravenous doses of BTT-1023 or placebo. During the trial, the safety of the treatments and the pharm...
Eligibility Criteria
Inclusion
- adult-onset rheumatoid arthritis
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00851240
Start Date
February 1 2009
End Date
November 1 2009
Last Update
February 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sofia, Bulgaria
Sofia, Bulgaria, 1612